首页> 外文学位 >Molecular analysis and pharmacogenetic assessment of calcium signaling pathway variation.
【24h】

Molecular analysis and pharmacogenetic assessment of calcium signaling pathway variation.

机译:钙信号传导途径变异的分子分析和药物遗传学评估。

获取原文
获取原文并翻译 | 示例

摘要

One in three American adults has hypertension. Less than half of those individuals have achieved blood pressure control despite the availability of efficacious pharmacotherapy. The current study aimed to determine whether genetic variation within Ca2+ signaling pathway genes may provide insight into the variability in responses observed to commonly used antihypertensives. Additionally, we sought to investigate the functional mechanisms of a clinically associated polymorphism found within this pathway.;Blood pressure (BP) response to atenolol and hydrochlorothiazide was evaluated relative to genetic variation among Ca2+ signaling pathway candidate genes among uncomplicated hypertensives. We identified several significant and novel associations within CACNA1C (calcium channel, voltage-dependent, L type, alpha 1c subunit) and BP response to atenolol among blacks.;We then evaluated the relationship between genetic variation of the Ca 2+ signaling pathway and clinical susceptibility to adverse cardiovascular outcomes in a high-risk cohort of hypertensives with coronary artery disease. Herein we identified several significant and novel pharmacogenetic treatment interactions among three different racial/ethnic groups. Additionally, several polymorphisms within CACNA1C significant for BP response among uncomplicated hypertensives also demonstrated significant associations with adverse cardiovascular outcomes in our high-risk cohort.;Finally, we used human vascular tissue to evaluate whether differential expression of mRNA, protein, or transcription factor binding could be observed relative to the clinically associated CACNB2 (calcium channel, voltage-dependent, beta 2 subunit) rs2357928 polymorphism. The current data show promising trends for an association with differential expression of mRNA, but definitive conclusions cannot be made due to a limiting sample size. Additional investigation is warranted, as the genetic associations reported here have yet to be replicated in an independent study population and a functional evaluation of molecular mechanisms would benefit greatly from a larger sample cohort.
机译:三分之一的美国成年人患有高血压。尽管有有效的药物治疗方法,但只有不到一半的人实现了血压控制。当前的研究旨在确定Ca2 +信号通路基因内的遗传变异是否可提供对常用降压药观察到的反应变异性的见解。此外,我们试图研究此途径内临床相关多态性的功能机制。相对于简单的高血压患者中Ca2 +信号通路候选基因之间的遗传变异,评估了对阿替洛尔和氢氯噻嗪的血压(BP)反应。我们在黑人中发现了CACNA1C(钙通道,电压依赖性,L型,α1c亚基)和BP对阿替洛尔的BP反应中的几个重要且新颖的关联;然后评估了Ca 2+信号传导途径的遗传变异与临床之间的关系。高血压合并冠心病的高危人群对不良心血管结果的敏感性。在本文中,我们确定了三个不同种族/族裔群体之间的几种重要且新颖的药物遗传学治疗相互作用。此外,在我们的高危人群中,CACNA1C内几个对BP反应具有重要意义的多态性也显示出与不良心血管预后的显着相关性;最后,我们使用人体血管组织来评估mRNA,蛋白质或转录因子结合的差异表达相对于临床相关的CACNB2(钙通道,电压依赖性,β2亚基)rs2357928多态性可以观察到。目前的数据显示与mRNA差异表达相关的良好趋势,但由于样本量有限,无法得出明确的结论。有必要进行进一步的研究,因为此处报道的遗传关联尚未在独立的研究人群中复制,并且分子机制的功能评估将受益于更大的样本队列。

著录项

  • 作者

    Davis, Heather Marie.;

  • 作者单位

    University of Florida.;

  • 授予单位 University of Florida.;
  • 学科 Pharmaceutical sciences.;Genetics.
  • 学位 Ph.D.
  • 年度 2012
  • 页码 106 p.
  • 总页数 106
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号